Joe Tidd
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Joe Tidd has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Frank M. Hull
Science and Technology Policy Research, Unit (SPRU), University of Sussex, Brighton, UK
2 shared publications - Paul Nightingale
University of Sussex
2 shared publications - Ben Thuriaux-Alemán
Arthur D. Little consultants
1 shared publication Eelko Huizingh
University of Groningen, Groningen, 9712 CP, Netherlands
1 shared publication- Kirsten Bodley
KPMG, London
1 shared publication - Matias Ramirez
University of Sussex, UK
1 shared publication
Latest Publications
- 1 June 2023
- Published by World Scientific Pub Co Pte Ltd in International Journal of Innovation Management
- Vol. 27 (05)
EDITORIAL — 25TH SPECIAL ISSUE FOR THE ISPIM: INNOVATION AND CIRCULAR ECONOMY
- 1 June 2023
- Published by World Scientific Pub Co Pte Ltd in International Journal of Innovation Management
- Vol. 27 (05)
EDITORIAL — 25TH SPECIAL ISSUE FOR THE ISPIM: INNOVATION AND CIRCULAR ECONOMY
- 25 January 2016
- Published by Wiley in R&D Management
- Vol. 46 (S3) , 1024-1043
Innovation management practices: cross‐sectorial adoption, variation, and effectiveness
Innovation management practices (IMPs) represent the codification of innovation research and management experience, and offer the potential to improve innovation performance. Studies suggest limited awareness of IMPs amongst practitioners, and even lower rates of application, and we know little of their perceived importance or effectiveness in different industries. Our paper assesses the use of eight functional groups of IMPs within and across sectors, drawing on a sample of 292 valid responses, based on survey data and associated and validated case studies. Overall, we find significant variation in usage patterns across sectors and a positive relationship between the use of IMPs and innovation outcomes. However, only a very small number of innovation management practices can be considered to be universally positive, including external technology intelligence gathering, and technology and product portfolio management. We find that the use and effectiveness of most IMPs varies by industry. This suggests there is significant potential for the more widespread application of some IMPs, but that managers must be highly selective.
- 25 January 2016
- Published by Wiley in R&D Management
- Vol. 46 (S3) , 1024-1043
Innovation management practices: cross‐sectorial adoption, variation, and effectiveness
Innovation management practices (IMPs) represent the codification of innovation research and management experience, and offer the potential to improve innovation performance. Studies suggest limited awareness of IMPs amongst practitioners, and even lower rates of application, and we know little of their perceived importance or effectiveness in different industries. Our paper assesses the use of eight functional groups of IMPs within and across sectors, drawing on a sample of 292 valid responses, based on survey data and associated and validated case studies. Overall, we find significant variation in usage patterns across sectors and a positive relationship between the use of IMPs and innovation outcomes. However, only a very small number of innovation management practices can be considered to be universally positive, including external technology intelligence gathering, and technology and product portfolio management. We find that the use and effectiveness of most IMPs varies by industry. This suggests there is significant potential for the more widespread application of some IMPs, but that managers must be highly selective.
- 20 May 2014
- Published by Wiley in R&D Management
- Vol. 44 (3) , 248-264
Creating and capturing value from external knowledge: the moderating role of knowledge intensity
Business model innovation (BMI) often involves the acquisition of external resources, their integration with and adaptation to internal capabilities and the exploitation of these novel combinations to create and capture value in new ways. However, studies focusing on the relationships among capabilities, BMI and firm performance are rare. In this paper, we adopt broader measures of internal and external knowledge, which include codified intangibles such as patents and copyrights, and examine the effects the combinations and interactions have on sales growth based on a dataset of 310 firms from four European countries. Using the broader measure of knowledge, we find support for the curvilinear relationship reported in studies using research and development‐intensity as a proxy. However, we also find that firms with low levels of internal knowledge benefit most from an ‘optimal’ investment in externally generated knowledge, but the influence on sales growth is very sensitive to the degree of external knowledge acquired. By contrast, knowledge‐intensive firms are relatively freer in defining their knowledge sourcing strategy. We discuss the implications for exploiting knowledge and complementary assets in BMI.
- 20 May 2014
- Published by Wiley in R&D Management
- Vol. 44 (3) , 248-264
Creating and capturing value from external knowledge: the moderating role of knowledge intensity
Business model innovation (BMI) often involves the acquisition of external resources, their integration with and adaptation to internal capabilities and the exploitation of these novel combinations to create and capture value in new ways. However, studies focusing on the relationships among capabilities, BMI and firm performance are rare. In this paper, we adopt broader measures of internal and external knowledge, which include codified intangibles such as patents and copyrights, and examine the effects the combinations and interactions have on sales growth based on a dataset of 310 firms from four European countries. Using the broader measure of knowledge, we find support for the curvilinear relationship reported in studies using research and development‐intensity as a proxy. However, we also find that firms with low levels of internal knowledge benefit most from an ‘optimal’ investment in externally generated knowledge, but the influence on sales growth is very sensitive to the degree of external knowledge acquired. By contrast, knowledge‐intensive firms are relatively freer in defining their knowledge sourcing strategy. We discuss the implications for exploiting knowledge and complementary assets in BMI.
- 22 December 2010
- Published by Wiley in R&D Management
- Vol. 41 (1) , 44-60
Generative and degenerative interactions: positive and negative dynamics of open, user‐centric innovation in technology and engineering consultancies
The related concepts of open innovation and user‐centric innovation are currently popular in the literature on technology and innovation management. In this paper, we attempt to address two shortcomings to their practical application. First, the precise mechanisms supporting open and user innovation in different industrial contexts are poorly specified. Second, it is not clear under what circumstances they might become dysfunctional. We identify how the interaction of meso‐ and micro‐level mechanisms contribute to project‐based user‐centric innovation, based on a detailed characterization of the business activities of eight technology and engineering consultancies working across a range of sectors. We develop and illustrate the notion ofgenerative interaction, which describes a series of mechanisms that produce a self‐re‐enforcing ecology, which favours innovation and profitability. At the same time, we observe the opposite dynamics of self‐reinforcingdegenerative interactionlikely to produce a cycle of declining innovation and profitability. In the specific context of project‐based firms, we show that user‐centric, open innovation can affect performance negatively, and we discuss the consequences (positive and negative) of different patterns of interaction with clients.
- 22 December 2010
- Published by Wiley in R&D Management
- Vol. 41 (1) , 44-60
Generative and degenerative interactions: positive and negative dynamics of open, user‐centric innovation in technology and engineering consultancies
The related concepts of open innovation and user‐centric innovation are currently popular in the literature on technology and innovation management. In this paper, we attempt to address two shortcomings to their practical application. First, the precise mechanisms supporting open and user innovation in different industrial contexts are poorly specified. Second, it is not clear under what circumstances they might become dysfunctional. We identify how the interaction of meso‐ and micro‐level mechanisms contribute to project‐based user‐centric innovation, based on a detailed characterization of the business activities of eight technology and engineering consultancies working across a range of sectors. We develop and illustrate the notion ofgenerative interaction, which describes a series of mechanisms that produce a self‐re‐enforcing ecology, which favours innovation and profitability. At the same time, we observe the opposite dynamics of self‐reinforcingdegenerative interactionlikely to produce a cycle of declining innovation and profitability. In the specific context of project‐based firms, we show that user‐centric, open innovation can affect performance negatively, and we discuss the consequences (positive and negative) of different patterns of interaction with clients.
- 31 March 2010
- Published by Edward Elgar Publishing
Service Innovation: Development, Delivery and Performance
- 31 March 2010
- Published by Edward Elgar Publishing
Service Innovation: Development, Delivery and Performance
- 1 March 2002
- Published by Wiley in R&D Management
- Vol. 32 (2) , 127-138
The influence of project novelty on the new product development process
In this paper we review the range of formal tools and techniques available to support the new product development process, and examine the use and usefulness of these by means of a survey of 50 projects in 25 firms. For each firm, we compare routine and novel development projects, and identify the influence of project novelty on the frequency of use and perceived usefulness of a range of different tools and methods. In terms of usefulness, focus groups, partnering customers and lead users and prototyping are all considered to be more effective for high novelty projects, and segmentation least useful. Cross‐functional development teams are commonplace for all types of project, but are significantly more effective for the high novelty cases. In addition, many tools rated as useful are not commonly used, and conversely some tools in common use are considered to be of limited use.
- 1 March 2002
- Published by Wiley in R&D Management
- Vol. 32 (2) , 127-138
The influence of project novelty on the new product development process
In this paper we review the range of formal tools and techniques available to support the new product development process, and examine the use and usefulness of these by means of a survey of 50 projects in 25 firms. For each firm, we compare routine and novel development projects, and identify the influence of project novelty on the frequency of use and perceived usefulness of a range of different tools and methods. In terms of usefulness, focus groups, partnering customers and lead users and prototyping are all considered to be more effective for high novelty projects, and segmentation least useful. Cross‐functional development teams are commonplace for all types of project, but are significantly more effective for the high novelty cases. In addition, many tools rated as useful are not commonly used, and conversely some tools in common use are considered to be of limited use.
- 1 June 2000
- Published by SAGE Publications in The International Journal of Entrepreneurship and Innovation
- Vol. 1 (2) , 109-116
Spin-In or Spin-Out?
This paper examines the variety of corporate venturing activities in the pharmaceutical and life science sectors, identifies the range of initiators, motives and structures, and evaluates the potential opportunities for professional venture capital firms. On the one hand, pharmaceutical companies need to maintain the new product pipeline that has increased the demand for technology acquisition, and on the other, mergers and rationalization within the sector have resulted in a significant growth in technology divestment. Both trends have boosted corporate venturing activity. The study examines the venture activities of nine pharmaceutical firms, fourteen life science companies and seven corporate venture capital funds. The authors conclude that, while there is a wide range of venturing options, there is considerable confusion in the industry over ends and means. Specifically, many firms have failed to differentiate sufficiently between strategic, financial and operational goals, and have therefore created inappropriate forms of corporate venture.
- 1 June 2000
- Published by SAGE Publications in The International Journal of Entrepreneurship and Innovation
- Vol. 1 (2) , 109-116
Spin-In or Spin-Out?
This paper examines the variety of corporate venturing activities in the pharmaceutical and life science sectors, identifies the range of initiators, motives and structures, and evaluates the potential opportunities for professional venture capital firms. On the one hand, pharmaceutical companies need to maintain the new product pipeline that has increased the demand for technology acquisition, and on the other, mergers and rationalization within the sector have resulted in a significant growth in technology divestment. Both trends have boosted corporate venturing activity. The study examines the venture activities of nine pharmaceutical firms, fourteen life science companies and seven corporate venture capital funds. The authors conclude that, while there is a wide range of venturing options, there is considerable confusion in the industry over ends and means. Specifically, many firms have failed to differentiate sufficiently between strategic, financial and operational goals, and have therefore created inappropriate forms of corporate venture.